AAN issues review of evidence for aducanumab in Alzheimer’s disease
Mar 03, 2022
A class I study shows that single doses of aducanumab are safe and well-tolerated; class II studies show reduced amyloid deposition on brain PET at one year.
Risk for progression to severe COVID-19 lower with nirmatrelvir + ritonavir
Mar 01, 2022
Treatment of symptomatic COVID-19 with nirmatrelvir plus ritonavir was linked to an 89% lower risk for progression versus placebo.
CDC loosens mask guidelines as omicron surge subsides
Feb 25, 2022
Under new recommendations, >70% of Americans now live in areas where masking in public indoor settings is no longer advised.
CDC close to new guidance on COVID-19 restrictions
Feb 24, 2022
The agency wants to give more emphasis to meaningful consequences, such as hospitalizations, emergency room visits and deaths.
Mental disorders tied to subsequent dementia onset
Feb 23, 2022
Associations were consistent across different psychiatric conditions, for Alzheimer’s disease and all other dementias.
Baricitinib reduces mortality in critically ill adults with COVID-19
Feb 18, 2022
A reduction in death was seen at 28 and 60 days for patients receiving invasive mechanical ventilation and extracorporeal membrane oxygenation.
Remdesivir offers some benefit for hospitalized COVID-19 patients
Feb 01, 2022
No difference was seen for in-hospital mortality, but a need for initiation of mechanical ventilation was reduced with the addition of remdesivir to standard care.
‘Stealth’ version of omicron variant no cause for alarm, experts say
Jan 31, 2022
The new version of the variant does not appear to cause more severe disease, and vaccines are effective against it.
Neutralization titers against omicron up with mRNA-1273 boost
Jan 28, 2022
After a mRNA-1273 (Moderna) boost, neutralization titers against the omicron variant were 20 times higher than than those at one month after second dose.
Omicron linked to increase in COVID-19 cases, lower disease severity
Jan 27, 2022
The mean length of stay and percentages admitted to the ICU, receiving invasive mechanical ventilation and dying were lower during omicron.